7459 — Medipal Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Annual income statement for Medipal Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,211,125	3,290,921	3,360,008	3,558,732	3,671,328
Cost of Revenue
Gross Profit	214,213	217,445	224,305	246,655	255,759
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,187,304	3,250,430	3,318,994	3,509,827	3,615,837
Operating Profit	23,821	40,491	41,014	48,905	55,491
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	49,237	57,284	70,061	74,741	76,734
Provision for Income Taxes
Net Income After Taxes	33,616	39,197	48,323	51,768	51,531
Minority Interest
Net Income Before Extraordinary Items
Net Income	23,927	29,425	38,806	41,475	40,281
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	23,823	29,320	38,752	41,474	40,279
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	152	148	206	196	201
Dividends per Share